Inventor · disambiguated record
Daniel Christopher Brookings
Also filed as: BROOKINGS DANIEL C · BROOKINGS DANIEL CHRISTOPHER
37 granted patents·7 pending applications·135 citations·filing 2000–2024
96Inventor score
Files withUCB BIOPHARMA SPRL13UCB PHARMA SA10UCB Biopharma SRL9CELLTECH R&D LTD3BROOKINGS DANIEL CHRISTOPHER2
Top patents by PatentIndex Score
44 records- 0188US8394822B2Thieno-pyridine derivatives as MEK inhibitorsHUTCHINGS MARTIN CLIVE·Filed 2012·Granted Mar 12, 2013·13 cites·20 claims
- 0287US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 0385US10906919B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2018·Granted Feb 2, 2021·2 cites·10 claims
- 0485US9873703B2Imidazopyridazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 23, 2018·8 cites·8 claims
- 0583US8283359B2Thieno-pyridine derivatives as MEK inhibitorsHUTCHINGS MARTIN CLIVE·Filed 2008·Granted Oct 9, 2012·6 cites·16 claims
- 0682US10202405B2Fused pentacyclic imidazole derivativesUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 12, 2019·4 cites·11 claims
- 0782US7521460B2Thienopyridone derivatives as kinase inhibitorsUCB PHARMA SA·Filed 2004·Granted Apr 21, 2009·17 cites·11 claims
- 0881US7592455B2Bicyclic heteroaromatic compounds as kinase inhibitorsUCB PHARMA SA·Filed 2003·Granted Sep 22, 2009·16 cites·6 claims
- 0980US2025127795A1Fused Pentacyclic Imidazole Derivatives as Modulators of TNF ActivityUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 1079US2023250105A1Fused Pentacyclic Imidazole Derivatives as Modulators of TNF ActivityUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 1177US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 1276US7763729B2Bicyclic heteroaromatic derivativesUCB PHARMA SA·Filed 2008·Granted Jul 27, 2010·2 cites·19 claims
- 1376US7423047B2Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitorsCELLTECH R&D LTD·Filed 2003·Granted Sep 9, 2008·8 cites·18 claims
- 1475US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 1574US9475820B2Substituted imidazo[1,2-a]pyrazines as TNF activity modulatorsUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 25, 2016·3 cites·14 claims
- 1674US7888344B2Fused thiazole derivatives as kinase inhibitorsUCB PHARMA SA·Filed 2006·Granted Feb 15, 2011·3 cites·16 claims
- 1772US8604051B2Thieno-pyridine derivatives as MEK inhibitorsUCB PHARMA SA·Filed 2013·Granted Dec 10, 2013·1 cites·20 claims
- 1870US9227984B2Therapeutically active fused pyrimidine derivativesBROOKINGS DANIEL CHRISTOPHER·Filed 2012·Granted Jan 5, 2016·2 cites·11 claims
- 1970US9096614B2Therapeutically active thiazolo-pyrimidine derivativesUCB PHARMA SA·Filed 2012·Granted Aug 4, 2015·2 cites·10 claims
- 2070US6716878B1Antimicrobial agentsVERNALIS OXFORD LTD·Filed 2000·Granted Apr 6, 2004·8 cites·24 claims
- 2170US2021252012A1Fused Pentacyclic Imidazole Derivatives as Modulators of TNF ActivityUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2269US10053464B2Triazolopyridazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Aug 21, 2018·1 cites·6 claims
- 2369US9957255B2Benzotriazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 1, 2018·1 cites·8 claims
- 2469US9932342B2Imidazopyrimidine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·1 cites·6 claims
- 2569US9902720B2Pyrazolopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 27, 2018·1 cites·6 claims
- 2669US9850240B2Triazolopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Dec 26, 2017·1 cites·7 claims
- 2768US9714251B2Imidazotriazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 2867US11912721B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2020·Granted Feb 27, 2024·0 cites·16 claims
- 2967US8350037B2Thieno-pyridine derivatives as MEK inhibitorsUCB PHARMA SA·Filed 2010·Granted Jan 8, 2013·1 cites·8 claims
- 3067US7176215B2Bicyclic oxopyridine and oxopyrimidine derivativesCELLTECH R&D LTD·Filed 2002·Granted Feb 13, 2007·3 cites·15 claims
- 3165US10980814B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2018·Granted Apr 20, 2021·0 cites·6 claims
- 3263US8487101B2Thieno-pyridine derivatives as MEK inhibitorsBROOKINGS DANIEL CHRISTOPHER·Filed 2010·Granted Jul 16, 2013·1 cites·18 claims
- 3362US7323464B2Pyridine and pyrimidine derivativesCELLTECH R&D LTD·Filed 2002·Granted Jan 29, 2008·3 cites·14 claims
- 3459US7456286B2Bicyclic heteroaromatic compounds as kinase inhibitorsUCB PHARMA SA·Filed 2003·Granted Nov 25, 2008·1 cites·4 claims
- 3557US8637491B2Thieno-pyridine derivatives as MEK inhibitorsJOHNSON JAMES ANDREW·Filed 2010·Granted Jan 28, 2014·1 cites·21 claims
- 3655US2024294534A1Imidazotriazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 3748US2010179185A1Novel Aminothienopyridinone Derivatives Processes for Preparing Them and Pharmaceutical Compositions ThereofUCB PHARMA SA·Filed 2007·Application pending·0 cites
- 3847US11458124B2Spirocyclic indane analogues as IL-17 modulatorsUCB Biopharma SRL·Filed 2019·Granted Oct 4, 2022·0 cites·15 claims
- 3946US2006247269A1Thienopyridone derivatives as kinase inhibitorsBROOKINGS DANIEL C·Filed 2004·Application pending·0 cites
- 4045US2009264411A1Fused thiophene derivatives as mek inhibitorsUCB PHARMA SA·Filed 2009·Application pending·0 cites
- 4144US8324204B2Fused thiophene derivatives as kinase inhibitorsALEXANDER RIKKI PETER·Filed 2007·Granted Dec 4, 2012·0 cites·6 claims
- 4243US10953019B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2018·Granted Mar 23, 2021·0 cites·12 claims
- 4341US9382263B2Therapeutically active oxazoline derivativesUCB BIOPHARMA SPRL·Filed 2013·Granted Jul 5, 2016·0 cites·14 claims
- 4429US9029392B2Quinoline derivatives as kinase inhibitorsPARTON ANDREW HARRY·Filed 2011·Granted May 12, 2015·0 cites·40 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Christopher Brookings files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →